Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oxisuran reduction by rabbit tissue preparations.

N R Bachur, R L Felsted

    Drug Metabolism and Disposition: the Biological Fate of Chemicals
    |May 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Bis-benzimidazole anticancer agents: targeting human tumour helicases.

    Anti-cancer drug design·1999
    Same author

    Antihelicase action of CI-958, a new drug for prostate cancer.

    Cancer chemotherapy and pharmacology·1998
    Same author

    Anthracycline antibiotic blockade of SV40 T antigen helicase action.

    Biochemical pharmacology·1998
    Same author

    Human N-myristoyltransferase amino-terminal domain involved in targeting the enzyme to the ribosomal subcellular fraction.

    The Journal of biological chemistry·1997
    Same author

    Inhibitors of human immunodeficiency virus type 1 zinc fingers prevent normal processing of gag precursors and result in the release of noninfectious virus particles.

    Journal of virology·1996
    Same author

    Protein N-myristoylation as a chemotherapeutic target for cancer.

    Journal of the National Cancer Institute·1995
    Same journal

    Reduction of secondary 3-keto bile acids by aldo-keto reductase 1C1 and 1C4.

    Drug metabolism and disposition: the biological fate of chemicals·2026
    Same journal

    High-level expression of full-length human CYP2E1 in Escherichia coli: Comparison of full-length human CYP2E1 to truncated counterpart shows enhanced association with redox partners.

    Drug metabolism and disposition: the biological fate of chemicals·2026
    Same journal

    Construction of a curated human pharmacokinetics database for molecular fragment analysis and machine learning applications.

    Drug metabolism and disposition: the biological fate of chemicals·2026
    Same journal

    Finding the dispersion number (D<sub>N</sub>) of the dispersion model from perfused rat and human liver studies.

    Drug metabolism and disposition: the biological fate of chemicals·2026
    Same journal

    Role of organic anion transporting polypeptides in pancreatic statin disposition and islet cell function in mice.

    Drug metabolism and disposition: the biological fate of chemicals·2026
    Same journal

    The regulatory potential of cytochrome P450-adrenodoxin interactions: Insights toward understanding redox partner regulation in drug metabolizing enzymes.

    Drug metabolism and disposition: the biological fate of chemicals·2026
    See all related articles

    Rabbit liver enzymes reduce oxisuran to oxisuranol, a process dependent on NADPH. This enzymatic reduction occurs in multiple organs, yielding two diastereoisomeric products.

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Drug Metabolism

    Background:

    • Oxisuran is a pyridine derivative.
    • Understanding oxisuran metabolism is crucial for its pharmacological applications.

    Purpose of the Study:

    • To investigate the enzymatic reduction of oxisuran.
    • To identify the enzymes and cofactors involved in oxisuran metabolism.
    • To characterize the metabolic products of oxisuran.

    Main Methods:

    • Incubation of oxisuran with cytoplasmic enzyme extracts from various rabbit organs.
    • Enzyme assays using NADPH as a cofactor.
    • Thin-layer chromatography and mass spectrometry for product identification.

    Main Results:

    Related Experiment Videos

    • Cytoplasmic enzymes in rabbit liver, kidney, brain, intestine, and lung reduce oxisuran to oxisuranol.
    • The liver cytoplasmic enzyme requires NADPH and has an optimal pH of 6.0.
    • Two diastereoisomeric oxisuranol products were formed.
    • Enzymatic activity was also detected in liver mitochondria.

    Conclusions:

    • Oxisuran undergoes significant enzymatic reduction in multiple rabbit tissues.
    • The primary metabolic pathway involves NADPH-dependent cytoplasmic enzymes.
    • The formation of two diastereoisomers suggests stereoselective metabolism.